Biocenter Finland has appointed a new Scientific Advisory Board (SAB) to support the development of Finnish life science research infrastructures. The SAB brings together internationally recognized leaders across Europe with expertise spanning the entire life science field from genomics and proteomics to structural biology, imaging, and scientific infrastructures.
The SAB’s role is to provide independent international evaluation of Biocenter Finland’s operations and offer advice on strategy and long-term development, ensuring that Finnish infrastructure remains internationally competitive and serves the research community effectively.
“The appointment of our new Scientific Advisory Board marks an important step for Biocenter Finland. Their international experience and perspectives will help us strengthen our platforms and anticipate the needs of future research,” said Olli Silvennoinen, Director of Biocenter Finland.
The Members of Biocenter Finland SAB are:
Carl-Henrik Heldin, Chair of the SAB. Professor of Molecular Cell Biology, Uppsala University, Sweden.
Søren Brunak, Professor, Dept. of Public Health & Novo Nordisk Foundation Center for Protein Research, University of Copenhagen, Denmark.
Kristina Djinovic Carugo, Professor, Head of EMBL Grenoble, European Molecular Biology Laboratory (EMBL) Grenoble, France & Department of Structural and Computational Biology, Max Perutz Labs, University of Vienna, Austria.
Jan Ellenberg, Director, SciLifeLab, Professor, Karolinska Institutet, Stockholm University & KTH Royal Institute of Technology, Sweden.
Jussi Helppi, Head of Biomedical Services, Speaker of Services and Facilities, Max Planck Institute of Molecular Cell Biology and Genetics, Dresden Germany.
Saskia Lippens, Deputy Director of VIB Technologies Program, VIB, Flemish Institute for Biotechnology, Belgium.
Mònica Morales, Head of Core Technologies Programme, Center of Genomic Regulation, Barcelona, Spain.
Ole Nørregaard Jensen, Professor, Department of Biochemistry and Molecular Biology, University of Southern Denmark
Jutta Steinkötter, Executive Management Scientific Infrastructure, Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany
“I am honored to chair this SAB and to work with Biocenter Finland,” said Carl-Henrik Heldin, Chair of the SAB and Professor of Molecular Cell Biology at Uppsala University. “Finland’s coordinated approach to research infrastructures is impressive, and we look forward to contributing to its continued success.”
With the new SAB, Biocenter Finland strengthens its international networks and continues its mission of supporting excellent research through state-of-the-art infrastructures.
The SAB will meet regularly with Biocenter Finland and its technology platforms, beginning with their first visit during Biocenter Finland Day 2025 in Helsinki.
